Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Fortical phase I dosing data revised

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Vasodilator cream shows positive results in trials

June 28, 1996

Zonagen's Vasomax covered under U.S. patent

June 28, 1996

Merck & Co. reveals growth hormone release promoters

June 28, 1996

Exocell granted U.S. patent for A717

June 28, 1996

Sankyo to file NDA for Noscal

June 28, 1996

HemAssist to enter phase III

June 28, 1996

SomatoKine covered under U.S. patent

June 28, 1996

Apolipoprotein B synthesis inhibitors reported

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...